Public Health

Enzyme a potential target in chikungunya arthritis

New research has revealed a potential drug target for chikungunya related arthritis. Professor Andreas Suhrbier, head of the Inflammation Biology Laboratory at QIMR Berghofer, told the limbic it was previously thought an interferon response drove the inflammation seen in chikungunya arthritis. However his research team has found the protease granzyme A is the major player ...

Already a member?

Login to keep reading.

© 2021 the limbic